Does Single Ventricle Physiology Affect Survival of Children Requiring Extracorporeal Membrane Oxygenation Support Following Cardiac Surgery?

  • Bahaaldin Alsoufi
    Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  • Abid Awan
    Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  • Cedric Manlhiot
    Labatt Family Heart Center, Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada
  • Zohair Al-Halees
    Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  • Mamdouh Al-Ahmadi
    Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  • Brian W. McCrindle
    Labatt Family Heart Center, Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada
  • Abdullah Alwadai
    Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

この論文をさがす

説明

<jats:sec><jats:title>Background:</jats:title><jats:p> Improved survival with postoperative extracorporeal membrane oxygenation (ECMO) has expanded its application to children with single ventricle (SV) anomalies. We examine current-era outcomes of postoperative ECMO with special focus on patients with SV. </jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p> Demographic, anatomic, surgical, and support details of 100 consecutive children requiring postoperative ECMO (2007-2012) were included into multivariable regression models to identify factors affecting survival. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> Median age was 73 days (4 days-16.2 years), 31 patients had SV physiology. The ECMO indication was failure to wean cardiopulmonary bypass (34%) and postoperative low cardiac output (66%) including 37% having extracorporeal cardiopulmonary resuscitation (ECPR). Median ECMO duration was four days (1-21). The ECMO decannulation and survival to hospital discharge were 62% and 37%. In SV group, decannulation and survival rates were 55% and 32%. The SV-ECMO outcomes were best in ECPR subgroup (54%), following shunt (57%) or Norwood (46%) and worst following Glenn, Fontan, or total anomalous pulmonary venous connection repair (0% survival). On multivariable analysis, factors affecting odds of survival were performing angiogram (odds ratio [OR]: 15.28, confidence interval [CI]: 2.34-99.89, P = .004), prolonged ECMO duration (OR: 0.64, CI: 0.47-0.88 per day, P = .005), leaving cannulation snares (OR: 28.41, CI: 2.65-304.70, P = .006), higher HCO<jats:sub>3</jats:sub> (OR: 1.19, CI: 1.04-1.36, P = .01), renal failure requiring hemodialysis (OR: 0.21, CI: 0.06-0.76, P = .02), bleeding requiring re-exploration (OR: 0.21, CI: 0.06-0.75, P = .02), ECPR in patients with SV (OR: 11.84, CI: 1.11-126.07, P = .04), delayed lactate normalization (OR: 0.95, CI: 0.90-0.99 per hour, P = .02), and elevated liver enzymes (OR: 0.97, CI: 0.95-1.00 per 10 unit/L, P = .05). </jats:p></jats:sec><jats:sec><jats:title>Conclusions:</jats:title><jats:p> The ECMO is valuable in patients with SV however results depend on anatomy, procedure, and support indication. Persistent markers of poor perfusion, end-organ injury, and prolonged ECMO duration are associated with mortality. Those factors could be modified by early ECMO application before organ damage, meticulous homeostasis to ensure adequate perfusion, early diagnosis, and reoperation on residual lesions to expedite weaning. </jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ